212 related articles for article (PubMed ID: 18415081)
1. The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.
Smith JA; Beattie DT; Marquess D; Shaw JP; Vickery RG; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):125-37. PubMed ID: 18415081
[TBL] [Abstract][Full Text] [Related]
2. The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.
Beattie DT; Armstrong SR; Shaw JP; Marquess D; Sandlund C; Smith JA; Taylor JA; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):139-47. PubMed ID: 18408918
[TBL] [Abstract][Full Text] [Related]
3. The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT
Tsubouchi T; Kunimatsu T; Tsujimoto S; Kiyoshi A; Katsura Y; Oku S; Chihara K; Mine Y; Yamada T; Shimizu I; Bando K
Eur J Pharmacol; 2018 May; 826():96-105. PubMed ID: 29501863
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
[TBL] [Abstract][Full Text] [Related]
5. An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954.
Beattie DT; Higgins DL; Ero MP; Amagasu SM; Vickery RG; Kersey K; Hopkins A; Smith JA
Vascul Pharmacol; 2013 Jan; 58(1-2):150-6. PubMed ID: 23201772
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.
Vickery RG; Mai N; Kaufman E; Beattie DT; Pulido-Rios T; O'Keefe M; Humphrey PP; Smith JA
Br J Pharmacol; 2007 Mar; 150(6):782-91. PubMed ID: 17293885
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.
Armstrong SR; McCullough JL; Beattie DT
J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.
Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT(4) receptor.
Komada T; Matsuura T; Mikami T; Suzuki K; Sugimoto H; Kimura N; Ohmi T; Toga T; Nakai Y; Eda H; Sakakibara M
Pharmacol Res; 2009 Oct; 60(4):237-46. PubMed ID: 19717010
[TBL] [Abstract][Full Text] [Related]
10. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
Toga T; Kohmura Y; Kawatsu R
J Pharmacol Sci; 2007 Oct; 105(2):207-10. PubMed ID: 17928736
[TBL] [Abstract][Full Text] [Related]
11. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs.
Inui A; Yoshikawa T; Nagai R; Yoshida N; Ito T
Jpn J Pharmacol; 2002 Dec; 90(4):313-20. PubMed ID: 12501007
[TBL] [Abstract][Full Text] [Related]
12. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound.
Briejer MR; Bosmans JP; Van Daele P; Jurzak M; Heylen L; Leysen JE; Prins NH; Schuurkes JA
Eur J Pharmacol; 2001 Jun; 423(1):71-83. PubMed ID: 11438309
[TBL] [Abstract][Full Text] [Related]
13. The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties.
Beattie DT; Armstrong SR; Vickery RG; Tsuruda PR; Campbell CB; Richardson C; McCullough JL; Daniels O; Kersey K; Li YP; Kim KH
Front Pharmacol; 2011; 2():25. PubMed ID: 21687517
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
[TBL] [Abstract][Full Text] [Related]
17. DSP-6952, a novel 5-HT
Mine Y; Itakura T; Oku S; Asada R; Shimizu I
Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
[TBL] [Abstract][Full Text] [Related]
18. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
19. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
